VC  Biomatics Capital

     Office Locations:

719 Second Avenue, Suite 1402
Seattle, WA 98104
Phone: 206-438-1822



  • Early



  • Life Sciences & Healthcare
  • Medical Device



    Founded in 2016 by Dr. Boris Nikolic and Julie Sunderland, Biomatics Capital is a for-profit venture firm investing in transformational innovation at the intersection of health care and technology. Managing Directors Dr. Boris Nikolic and Julie Sunderland have invested together in emerging technology, health care and life science ventures since 2010. Biomatics closed its initial fund of $200 million, in excess of the fund target of $150 million. Biomatics estimates that it will invest in 15-20 companies through this fund, acting as Series A lead investor in a majority of the deals. Initial investments typically range from $5 million to $10 million, with up to $20 million over the life of the investment.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Dr. Boris Nikolic Managing Director
    Julie Sunderland Managing Director


    Recent Funding Events (trailing 12 months):







      Verve Therapeutics



      Series B


    Portfolio companies include:


    Recent News: